Overview

Nonopioid Analgesia After Labral Surgery

Status:
Unknown status
Trial end date:
2020-05-20
Target enrollment:
0
Participant gender:
All
Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Henry Ford Health System
Treatments:
Acetaminophen
Acetaminophen, hydrocodone drug combination
Analgesics, Non-Narcotic
Celecoxib
Diazepam
Gabapentin
Hydrocodone
Ketorolac
Ketorolac Tromethamine
Oxycodone
Criteria
Eligibility Criteria:

Inclusion Criteria:

- All adult patients over age 18 and scheduled for a primary or revision labral surgery

Exclusion Criteria:

- Exclusion criteria will include patients with a medical history of known allergies or
intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin,
dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of
narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI
bleeding. Secondary exclusion criterion is an intact rotator cuff